{"pub_date": "2016-08-25T04:00:00+0000", "subsection_name": null, "lead_paragraph": "Researchers found that nearly half of women with early breast cancer can safely avoid the treatment with little risk of cancer recurring or spreading in five years.", "print_page": "10", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "GRADY", "firstname": "Denise", "role": "reported"}], "original": "By DENISE GRADY"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 564, "url": "images/2016/08/25/science/24CANCER5/24CANCER5-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "564", "xlarge": "images/2016/08/25/science/24CANCER5/24CANCER5-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Science", "headline": {"print_headline": "Gene Tests Identify Breast Cancer Patients Who Can Skip Chemo, Study Says", "main": "Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, Study Says"}, "source": "The New York Times", "blog": [], "word_count": "1225", "web_url": "http://www.nytimes.com/2016/08/25/science/gene-tests-identify-breast-cancer-patients-who-can-skip-chemotherapy-study-says.html", "slideshow_credits": null, "news_desk": "National", "type_of_material": "News", "snippet": "Researchers found that nearly half of women with early breast cancer can safely avoid the treatment with little risk of cancer recurring or spreading in five years....", "_id": "57be306a95d0e021d798271a", "abstract": "Study published in New England Journal of Medicine finds nearly half of women with early-stage breast cancer can skip chemotherapy with little risk of recurrence; researchers say by measuring activity of genes controlling growth and spread of cancer--so-called genome test--they can determine which patients would not benefit from chemo; findings reassure doctors who want to spare patients treatment's harsh side effects, although patients who skip chemo have slightly higher disease recurrence rates.", "keywords": [{"rank": "1", "name": "subject", "value": "Breast Cancer", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Chemotherapy", "is_major": "Y"}, {"rank": "3", "name": "organizations", "value": "New England Journal of Medicine", "is_major": "Y"}, {"rank": "4", "name": "persons", "value": "Cardoso, Fatima", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Tests (Medical)", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Genetics and Heredity", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "Women and Girls", "is_major": "N"}]}